Antares Pharma
ATRS
#5620
Rank
NZ$1.68 B
Marketcap
$9.88
Share price
0.00%
Change (1 day)
42.05%
Change (1 year)

Revenue for Antares Pharma (ATRS)

Revenue in 2021: NZ$0.32 Billion

According to Antares Pharma's latest financial reports the company's current revenue (TTM ) is NZ$0.32 Billion. In 2021 the company made a revenue of NZ$0.32 Billion an increase over the revenue in the year 2020 that were of NZ$0.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Antares Pharma from 1996 to 2021

Annual revenue

Year Revenue Change
2021NZ$0.32 B22.98%
2020NZ$0.26 B20.78%
2019NZ$0.21 B94.9%
2018NZ$0.11 B16.58%
2017NZ$96.39 M4.39%
2016NZ$92.33 M14.38%
2015NZ$80.73 M72.28%
2014NZ$46.86 M28.53%
2013NZ$36.45 M-8.67%
2012NZ$39.91 M37.17%
2011NZ$29.1 M28.39%
2010NZ$22.66 M54.24%
2009NZ$14.69 M46.82%
2008NZ$10 M-27.95%
2007NZ$13.89 M84.07%
2006NZ$7.54 M91.86%
2005NZ$3.93 M-18.98%
2004NZ$4.85 M-27.49%
2003NZ$6.69 M-5.23%
2002NZ$7.06 M14.21%
2001NZ$6.18 M75.52%
2000NZ$3.52 M-42.75%
1999NZ$6.15 M26.57%
1998NZ$4.86 M-25.99%
1997NZ$6.57 M0.68%
1996NZ$6.52 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$0.98 B 201.91%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$35.67 B 10,867.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.08 B 1,463.41%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$67.66 M-79.20%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$106.28 B 32,572.22%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.65 B 9,015.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$155.06 B 47,565.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$72.25 B 22,110.49%๐Ÿ‡บ๐Ÿ‡ธ USA